Inventor · disambiguated record
Christian Rene Schnell
Also filed as: SCHNELL CHRISTIAN · SCHNELL CHRISTIAN RENE · SCHNELL CHRISTIAN RENÉ
9 granted patents·13 pending applications·157 citations·filing 2007–2020
88Inventor score
Top patents by PatentIndex Score
22 records- 0195US8344128B2Short interfering ribonucleic acid (siRNA) for oral administrationNOVARTIS AG·Filed 2011·Granted Jan 1, 2013·38 cites·20 claims
- 0295US8084600B2Short interfering ribonucleic acid (siRNA) with improved pharmacological propertiesNATT FRANCOIS JEAN-CHARLES·Filed 2007·Granted Dec 27, 2011·58 cites·24 claims
- 0394US8404831B2Short interfering ribonucleic acid (siRNA) for oral administrationNATT FRANCOIS JEAN-CHARLES·Filed 2011·Granted Mar 26, 2013·31 cites·20 claims
- 0493US8404832B2Short interfering ribonucleic acid (siRNA) for oral administrationNATT FRANCOIS JEAN-CHARLES·Filed 2011·Granted Mar 26, 2013·27 cites·20 claims
- 0574US8741963B2S1P receptor modulators for treating multiple sclerosisHIESTAND PETER C·Filed 2011·Granted Jun 3, 2014·3 cites·9 claims
- 0663US9493771B2Short interfering ribonucleic acid (siRNA) for oral administrationNATT FRANCOIS JEAN-CHARLES·Filed 2014·Granted Nov 15, 2016·0 cites·13 claims
- 0761US8957041B2Short interfering ribonucleic acid (siRNA) for oral administrationNOVARTIS AG·Filed 2012·Granted Feb 17, 2015·0 cites·21 claims
- 0860US2021196696A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0957US9187405B2S1P receptor modulators for treating relasping-remitting multiple sclerosisHIESTAND PETER C·Filed 2014·Granted Nov 17, 2015·0 cites·6 claims
- 1057US2010280094A1Compositions and methods to treat muscular & cardiovascular disordersNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1154US2010168078A1S1p receptor modulators for treating multiple sclerosisHIESTAND PETER C·Filed 2007·Application pending·0 cites
- 1253US10434092B2Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2017·Granted Oct 8, 2019·0 cites·5 claims
- 1353US2020069670A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1449US2012114744A1Compositions and methods to treat muscular & cardiovascular disordersBEUVINK IWAN·Filed 2012·Application pending·0 cites
- 1548US2013209461A1Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family membersBRACHMANN SASKIA MARIA·Filed 2011·Application pending·0 cites
- 1648US2017000778A1Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitorDI TOMASO EMMANUELLE·Filed 2014·Application pending·0 cites
- 1747US2012041052A1Compositions and Methods to Treat Muscular & Cardiovascular DisordersBEUVINK IWAN·Filed 2011·Application pending·0 cites
- 1844US2014275089A12-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative DiseasesNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1943US2011301157A1Bicyclic amides as kinase inhibitorsBOLD GUIDO·Filed 2011·Application pending·0 cites
- 2039US2014302022A12-carboxamide clycloamino urea derivatives for use in treating vegf-dependent diseasesSCHNELL CHRISTIAN RENE·Filed 2012·Application pending·0 cites
- 2137US2018280370A1Dosage regimen for a phosphatidylinositol 3-kinase inhibitorNOVARTIS AG·Filed 2016·Application pending·0 cites
- 2237US2016199365A12-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative DiseasesHUANG XIZHONG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Rene Schnell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →